A chemical that is being researched for use in the therapy of cancer and heart disease. Abegrin attaches to a proteins on the outside of blood vessels, and it may block cancers from growing new blood vessels. It may also help to prevent cancer from spreading. It's a combination of an antiangiogenesis agent, a metastasis inhibitor, and a secondary antibody. Also known as etaracizumab, MEDI-522 humanised monoclonal antibody, and MEDI-522.